An Open label, Multicentre, Phase I study of Ibrutinib, Rituximab and EBV specific T-cells in Patients withEBV-positive Primary or Secondary CNS Lymphoma unsuitable for standard therapies

  • Gandhi, Maher (PI)
  • Polizzotto, Mark (PI)
  • Cheah, Chan Yoon (CoI)
  • Dolcetti, Riccardo (CoI)
  • Keane, Colm (CoI)
  • Krause, Lutz (CoI)
  • Mollee, P (CoI)
  • Scuffham, Paul A (CoI)
  • Slavin, Monica (CoI)
  • Teh, Benjamin (CoI)

    Project: Research

    Project Details

    StatusActive
    Effective start/end date1/12/2015/11/24